Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-848d4c4894-4hhp2 Total loading time: 0 Render date: 2024-05-18T01:41:09.742Z Has data issue: false hasContentIssue false

Chapter 27 - Fertility Prospects Related to Puberty Blocking Therapy

from Section E - Fertility and Reproduction

Published online by Cambridge University Press:  22 December 2022

By
Cynthia Dela Cruz  and
Molly B. Moravek
Edited by
Mick van Trotsenburg ,
Rixt A. C. Luikenaar  and
Maria Cristina Meriggiola
Mick van Trotsenburg
Affiliation:
Sigmund Freud PrivatUniversität, Wien
Rixt A. C. Luikenaar
Affiliation:
Rebirth Health Center, Utah
Maria Cristina Meriggiola
Affiliation:
Università di Bologna
Get access

Summary

Pubertal suppression is a treatment option for minors with gender incongruity and dysphoria and is recommended by the World Professional Association for Transgender Health (WPATH) and Endocrine Society. Unfortunately, there are limited data regarding the effect of gonadotropin-releasing hormone (GnRH) agonists, or “puberty blockers,” on future fertility in transgender and nonbinary youth. In this chapter, we will describe the potential consequences of GnRH agonist use for puberty blockade on later fertility, fertility preservation options depending on sex assigned at birth, and ethical implications in fertility preservation counseling before prescribing puberty blockers in adolescents.

Type
Chapter
Information
Context, Principles and Practice of TransGynecology
Managing Transgender Patients in ObGyn Practice
 , pp. 201 - 205
Publisher: Cambridge University Press
Print publication year: 2022

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

James, SE, Herman, JL, Rankin, S, et al. The Report of the U.S. Transgender Survey 2015. Available at: https://transequality.org/sites/default/files/docs/usts/USTS-Full-Report-Dec17.pdfGoogle Scholar
Wood, CL, Lane, LC, Cheetham, T. Puberty: normal physiology (brief overview. Best Pr Res Clin Endocrinol Metab 2019;33(3):101265.CrossRefGoogle ScholarPubMed
Conn, PM, Crowley, WF Jr. Gonadotropin-releasing hormone and its analogues. N Engl J Med 1991;324(2):93–103.Google Scholar
Raivio, T, Miettinen, PJ. Constitutional delay of puberty versus congenital hypogonadotropic hypogonadism: genetics, management and updates. Best Pr Res Clin Endocrinol Metab 2019;33(3):101316.Google Scholar
Khan, L. Puberty: onset and progression. Pediatr Ann 2019;48(4):e141–e145.Google Scholar
Tanner, JM, Davies, PS. Clinical longitudinal standards for height and height velocity for North American children. J Pediatr 1985;107(3):317–329.Google Scholar
Tanner, JM, Whitehouse, RH. Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Child 1976;51(3):170–179.CrossRefGoogle ScholarPubMed
Mahfouda, S, Moore, JK, Siafarikas, A, Zepf, FD, Lin, A. Puberty suppression in transgender children and adolescents. Lancet Diabetes Endocrinol 2017;5(10):816–826.Google Scholar
Cohen-Kettenis, PT, Steensma, TD, Vries, AL. Treatment of adolescents with gender dysphoria in the Netherlands. Child Adolesc Psychiatr Clin N Am 2011;20(4):689–700.Google Scholar
de Vries, ALC, Cohen-Kettenis, PT. Clinical management of gender dysphoria in children and adolescents: the Dutch approach. J Homosex 2012;59(3):301–320.Google Scholar
Hembree, WC, Cohen-Kettenis, PT, Gooren, L, et al. Endocrine treatment of gender-dysphoric/gender-incongruent persons: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2017;102(11):3869–3903.CrossRefGoogle ScholarPubMed
Panagiotakopoulos, L. Transgender medicine: puberty suppression. Rev Endocr Metab Disord 2018;19(3):221–225.Google Scholar
Tarlatzis, BC, Kolibianakis, EM. GnRH agonists vs antagonists. Best Pr Res Clin Obstet Gynaecol 2007;21(1):57–65.CrossRefGoogle ScholarPubMed
Pienkowski, C, Tauber, M. Gonadotropin-releasing hormone agonist treatment in sexual precocity. Endocr Dev 2016;29:214–229.Google Scholar
Lazar, L, Meyerovitch, J, de Vries, L, Phillip, M, Lebenthal, Y. Treated and untreated women with idiopathic precocious puberty: long-term follow-up and reproductive outcome between the third and fifth decades. Clin Endocrinol 2014;80(4):570–576.CrossRefGoogle ScholarPubMed
Heger, S, Müller, M, Ranke, M, et al. Long-term GnRH agonist treatment for female central precocious puberty does not impair reproductive function. Mol Cell Endocrinol 2006;254–255:217–220.Google Scholar
Feuillan, PP, Jones, JV, Barnes, KM, Oerter-Klein, K, Cutler, GB. Boys with precocious puberty due to hypothalamic hamartoma: reproductive axis after discontinuation of gonadotropin-releasing hormone analog therapy. J Clin Endocrinol Metab 2000;85(11):4036–4038.Google Scholar
Chen, M, Eugster, EA. Central precocious puberty: update on diagnosis and treatment. Paediatr Drugs 2015;17(4):273–281.Google Scholar
Neely, EK, Lee, PA, Bloch, CA, et al. Leuprolide acetate 1-month depot for central precocious puberty: hormonal suppression and recovery. Int J Pediatr Endocrinol 2010;2010:398639.Google Scholar
Coleman, E, Bockting, W, Botzer, M, et al. Standards of care for the health of transsexual, transgender, and gender-nonconforming people, Version 7. Int J Transgend 2012;13(4):165–232.Google Scholar
Gao, Y, Yu, B, Mao, J, et al. Assisted reproductive techniques with congenital hypogonadotropic hypogonadism patients: a systematic review and meta-analysis. BMC Endocr Disord 2018;18(1):85.CrossRefGoogle ScholarPubMed
Kim, SH. Congenital hypogonadotropic hypogonadism and Kallmann syndrome: past, present, and future. Endocrinol Metab Seoul 2015;30(4):456–466.CrossRefGoogle ScholarPubMed
Boehm, U, Bouloux, PM, Dattani, MT, et al. Expert consensus document: European Consensus Statement on congenital hypogonadotropic hypogonadism–pathogenesis, diagnosis and treatment. Nat Rev Endocrinol 2015;11(9):547–564.CrossRefGoogle ScholarPubMed
Young, J, Xu, C, Papadakis, GE, et al. Clinical management of congenital hypogonadotropic hypogonadism. Endocr Rev 2019;40(2):669–710.CrossRefGoogle ScholarPubMed
Xiao, S, Zhang, J, Romero, MM, et al. In vitro follicle growth supports human oocyte meiotic maturation. Sci Rep 2015;5:17323.CrossRefGoogle ScholarPubMed
Donnez, J, Dolmans, MM. Ovarian cortex transplantation: 60 reported live births brings the success and worldwide expansion of the technique towards routine clinical practice. J Assist Reprod Genet 2015;32(8):1167–1170.Google Scholar
Demeestere, I, Simon, P, Dedeken, L, et al. Live birth after autograft of ovarian tissue cryopreserved during childhood. Hum Reprod 2015;30(9):2107–2109.CrossRefGoogle ScholarPubMed
Poirot, C, Abirached, F, Prades, M, et al. Induction of puberty by autograft of cryopreserved ovarian tissue. Lancet 2012;379:9815.CrossRefGoogle ScholarPubMed
Ernst, E, Kjaersgaard, M, Birkebaek, NH, Clausen, N, Andersen, CY. Case report: stimulation of puberty in a girl with chemo- and radiation therapy induced ovarian failure by transplantation of a small part of her frozen/thawed ovarian tissue. Eur J Cancer 2013;49(4):911–914.Google Scholar
Lavery, SA, Islam, R, Hunt, J, Carby, A, Anderson, RA. The medical and ethical challenges of fertility preservation in teenage girls: a case series of sickle cell anaemia patients prior to bone marrow transplant. Hum Reprod 2016;31(7):1501–1507.Google Scholar
Estes, SJ. Fertility preservation in children and adolescents. Endocrinol Metab Clin North Am 2015;44(4):799–820.Google Scholar
Rothenberg, SS, Witchel, SF, Menke, MN. Oocyte cryopreservation in a transgender male adolescent. N Engl J Med 2019;380(9):886–887.Google Scholar
Martin, CE, Lewis, C, Omurtag, K. Successful oocyte cryopreservation using letrozole as an adjunct to stimulation in a transgender adolescent after GnRH agonist suppression. Fertil Steril 2021;116(2):522–527.Google Scholar
Hussein, AA, Yango, P, Ezz, Y, Smith, JF, Tran, ND. Fertility preservation options for prepubertal boys facing gonadotoxic therapies. Minerva Ginecol 2016;68(6):668–674.Google ScholarPubMed
Wyns, C, Curaba, M, Vanabelle, B, Van Langendonckt, A, Donnez, J. Options for fertility preservation in prepubertal boys. Hum Reprod Update 2010;16(3):312–328.CrossRefGoogle ScholarPubMed
Mattawanon, N, Spencer, JB, Schirmer, DA, Tangpricha, V. Fertility preservation options in transgender people: a review. Rev Endocr Metab Disord 2018;19(3):231–242.Google Scholar
Fayomi, AP, Peters, K, Sukhwani, M, et al. Autologous grafting of cryopreserved prepubertal rhesus testis produces sperm and offspring. Science 2019;363(6433):1314–1319.Google Scholar
Masliukaite, I, Hagen, JM, Jahnukainen, K, et al. Establishing reference values for age-related spermatogonial quantity in prepubertal human testes: a systematic review and meta-analysis. Fertil Steril 2016;106(7):1652–1657.CrossRefGoogle ScholarPubMed
DiNofia, AM, Wang, X, Yannekis, G, et al. Analysis of semen parameters in a young cohort of cancer patients. Pediatr Blood Cancer 2017;64(2):381–386.CrossRefGoogle Scholar
Brix, N, Ernst, A, Lauridsen, LLB, et al. Timing of puberty in boys and girls: a population-based study. Paediatr Perinat Epidemiol 2019;33(1):70–78.CrossRefGoogle ScholarPubMed
Juul, A, Teilmann, G, Scheike, T, et al. Pubertal development in Danish children: comparison of recent European and US data. Int J Androl 2006;29(1):86–90.CrossRefGoogle ScholarPubMed
Adeleye, AJ, Stark, BA, Jalalian, L, Mok-Lin, E, Smith, JF. Evidence of spermatogenesis in the presence of hypothalamic suppression and low testosterone in an adolescent transgender female: a case report. Transgend Health 2021:2021;trgh.2021.0034.Google Scholar
Koch, CA, Tangpricha, V. Gender dysphoria and transgender medicine in the year 2018. Rev Endocr Metab Disord 2018;19(3):193–195.Google Scholar
Gerth, J, Becerra-Culqui, T, Bradlyn, A, et al. Agreement between medical records and self-reports: implications for transgender health research. Rev Endocr Metab Disord 2018;19(3):263–269.Google Scholar
Korpaisarn, S, Safer, JD. Gaps in transgender medical education among healthcare providers: a major barrier to care for transgender persons. Rev Endocr Metab Disord 2018;19(3):271–275.CrossRefGoogle Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×